Pre-operative proteinuria in left ventricular assist devices and clinical outcome

Rahatullah Muslem, Kadir Caliskan, Sakir Akin, Kavita Sharma, Nisha A. Gilotra, Jasper J. Brugts, Brian Houston, Glenn Whitman, Ryan J. Tedford, Dennis A. Hesselink, Ad J. J. C. Bogers, Olivier C. Manintveld, Stuart D. Russell

Research output: Contribution to journalArticleAcademicpeer-review


Background This study evaluated the association of pre-operative proteinuria before continuous flow left ventricular assist device (CF-LVAD) implantation in relation to mortality and the need for renal replacement therapy (RRT) during the first year of follow-up. Methods This retrospective, multicenter cohort study evaluated all patients (n = 241) who underwent CF-LVAD implantation in the 2 participating tertiary referral centers. Patients were included if a urine dipstick was performed within 7 days before CF-LVAD implantation. Proteinuria was defined as trace or higher. Results In total, 173 patients (72%) were included (78% men; mean age, 52.3 ± 13.3; mean estimated glomerular filtration rate, 60.1 ± 25.9 mL/min/1.73 m2), and 42 patients (24%) had pre-operative proteinuria. The observed survival in patients with proteinuria vs without proteinuria was 57% vs 86% at 3 months and 52% vs 78% at 1 year (log-rank p < 0.001), respectively. In addition, during the first year after implantation, 32% of the patients with proteinuria and 15% of the patients without proteinuria required RRT (log-rank p = 0.02). Multivariate Cox regression analysis confirmed that pre-operative proteinuria was an independent predictor for mortality (adjusted hazard ratio, 2.09; 95% confidence interval, 1.10–3.80, p = 0.02) and for the need of RRT during the first year (adjusted hazard ratio, 2.23; 95% confidence interval, 1.13–4.84; p = 0.02). Conclusions Proteinuria, which was present in 25% of all tested LVAD patients, predicts worse outcome in all-cause mortality and need of RRT in patients with a CF-LVAD. This warrants the use of proteinuria in risk stratification when selecting patients for CF-LVAD therapy.
Original languageEnglish
Pages (from-to)124-130
JournalJournal of Heart and Lung Transplantation
Issue number1
Publication statusPublished - 2018
Externally publishedYes

Cite this